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N M WILSON, P M BROWN, S M JUUL, S A PRESTWICH, P H SONKSEN Abstract
Infusion of 67 g ethanol over four hours in fasted, nonobese normal men (a) induced hypoglycaemia by inhibiting gluconeogenesis; (b) produced noticeable increases in blood lactate, 3-hydroxybutyrate, and free fatty acid concentrations; (c) depressed plasma growth hormone concentrations, despite hypoglycaemia; and (d) raised plasma cortisol concentrations before significant hypoglycaemia occurred. These metabolic changes were explained by the reduction of redox state which accompanies ethanol oxidation. The pronounced changes in metabolic values recorded during this study suggested that the use of parenteral feeding regimens including ethanol needs to be reconsidered.
Introduction
Ethanol-induced hypoglycaemia was first described by Brown and Harvey in 1941. 1 The belief that chronic alcoholism was a prerequisite for the condition was refuted by several reports of its occurrence in children. Initially the hypoglycaemia was attributed to the hepatotoxicity of denatured alcohol solvents, and it was not until 1963 that ethanol alone was shown to be responsible.2 The pathophysiology of the condition is still not clear. The in-vitro studies of Freinkel et al3 indicated that inhibition of glucose production was responsible, while Searle et al,4 using metabolic tracer studies in vivo, implicated an increase in glucose utilisation.
In addition to its effect on glucose homoeostasis, ethanol metabolism reduces the cytosolic and mitochondrial redox states,' thus causing many changes in intermediary carbohydrate and fat metabolism. The effect of ethanol on the plasma free fatty acid concentration, however, is controversial: Freinkel et a12 reported a net rise, while Abramson and Arky6 observed a net fall. The response of ketone bodies is also not clear. Arky and Freinkel7 found a decline in blood acetoacetate concentration in response to ethanol oxidation, while Bagdade et al8 observed a rise. That insulin-induced hypoglycaemia leads to raised plasma growth hormone and cortisol concentrations is well known, but the hormonal response to acute alcohol ingestion is (Ra) and disappearance (Rd) of glucose were calculated by the method of Steele et al. 9 Lactate and pyruvate, 3-hydroxybutyrate, and acetoacetate were assayed in deproteinised blood by enzymatic spectrophotometry. Plasma free fatty acids were measured by fluorometry after Dole extraction. Plasma growth hormone, cortisol, and insulin were measured by radioimmunoassay using specific antisera, and plasma potassium by flame photometry.
Standard statistical analyses were by paired and unpaired t tests, Bessel's correction of variance for standard errors of the mean (SEM) being employed.
Results

BLOOD ETHANOL
Blood ethanol concentrations (table) increased steadily during infusion, reaching a peak 15-1 ± 0 7 mmol/l (69-6 ± 3-2 mg/100 ml; mean ± SEM) at 450 minutes, the end of the experiment. All subjects felt deeply intoxicated despite these relatively low blood ethanol concentrations.
PLASMA GLUCOSE, GLUCOSE TURNOVER, AND INSULIN Plasma glucose concentrations ( fig 1) were fairly constant at 3-7 mmol/l (66-7 mg/100 ml) during the equilibration period. These fell significantly (p < 0-01) during ethanol infusion, reaching a nadir of 22 ± 0-22 mmol/l (39-6 ± 4 0 mg/100 ml) 230 Rd also fell during ethanol infusion, but the fall began later than that of Ra and its magnitude was less (nadir 5-72 ± 0-62 ,umol/min/kg (1-03 ± 011 mg/min/kg) 200 minutes after start of infusion). Ra was significantly lower than Rd (p<0 05) during the period 230-350 minutes. Glucagon caused no significant change in Ra or Rd.
Plasma insulin concentration remained at or below 1 mU/l (the lower limit of the insulin radioimmunoassay) throughout the experiment, and there was no response to the glucagon injection. 
mmol/l (28-2 mg/100 ml). The initial fall in free fatty acid concentrations after the start of the ethanol infusion was followed by a significant rise to a plateau of 2-49 ± 0-2 mmol/l (63-7 ± 5-1 mg/100 ml) (p < 0 001), which was maintained from 390 minutes to the end of the experiment. Conversion: SI to traditional units-FFA: 1 mmol/l z25-6 mg/l00 ml.
GROWTH HORMONE AND CORTISOL
Characteristic fluctuations in plasma growth hormone concentration ( fig 3) were evident during the equilibration period. These were less apparent during ethanol infusion, and concentrations fell significantly to 2 70 ± 0-52 ,ug/i at 340 minutes (p < 0 05). The later rise was not significant.
Plasma cortisol concentration (fig 1) was steady at 340 nmol/l (12 ,ug/100 ml) during equilibration and rose to a peak of 654 4 50 nmol/l (24 ± 1 8 peg/100 ml) at the end of the experiment (p < 001). The rise was first significant at 300 minutes (p < 0 05).
POTASSIUM
The mean plasma potassium concentration (table) did not change significantly during the equilibration period, the immediate preinfusion value being 3-87 ± 0 04 mmol (mEq)/l. Ethanol infusion was accompanied by a fall to 3-38 L 0-04 mmol/l 220 minutes after the start of the infusion (p < 0 05).
Glucagon had no significant effect on lactate, pyruvate, 3-hydroxybutyrate, acetoacetate, free fatty acids, cortisol, or potassium.
Discussion BLOOD ETHANOL
All six subjects felt deeply intoxicated by the end of the experiment, and in view of the relatively low blood ethanol concentrations the hypoglycaemia probably partly accounted for this. At no time did blood ethanol concentrations exceed the legal limit for driving (370 mmol/l; 80 mg/100 ml).
PLASMA GLUCOSE, GLUCOSE TURNOVER, AND INSULIN
Our results show that ethanol induces hypoglycaemia in fasted subjects by inhibiting hepatic glucose production (Ra) . The lack of response of plasma glucose to glucagon administration indicates that the 36-hour fast had depleted hepatic glycogen. Ra therefore represents entirely gluconeogenesis. Ethanol thus caused hypoglycaemia by inhibiting gluconeogenesis. This concurs with the observation of Freinkel et al that the rate of '4C-alanine cycling to glucose is decreased in liver slices from alcohol-fed rats compared with controls.3 Glucose utilisation (Rd) fell during ethanol administration, probably due to declining substrate availability. This contrasts with the findings of Searle et al,4 who used a single bolus injection of 14C-6-glucose to measure glucose turnover during ethanol infusion in fasted subjects. In that study glucose turnover was calculated from small changes in the 14C-6-glucose specific activity decay curve. We have strong reservations about the accuracy of that method. Ethanol reportedly also inhibits gluconeogenesis in non-fasted subjects,10 but hypoglycaemia does not occur owing to accompanying glycogenolysis.1"
The continuously low insulin concentrations, which were to be expected after a 36-hour fast, were lower than those found under similar circumstances by Joffe et al. 12 Plasma insulin concentrations appeared to remain steady in our subjects. These were, however, below the lower limit of the assay for much of the experiment, and small variations may have gone undetected. Glucagon stimulates insulin release; nevertheless, the plasma insulin concentration failed to rise after glucagon administration, possibly because of the concomitant hypoglycaemia.
The increase in cytosolic and mitochondrial reduced nicotinamide-adenine-dinucleotide to oxidised nicotinamide-adeninedinucleotide (NADH :NAD +) ratios resulting from ethanol oxidation5 may be the cause of gluconeogenesis inhibition.
Ethanol is oxidised principally in the liver by three separate mechanisms: (1) in the cytosol-the alcohol dehydrogenase reaction; (2) in the endoplasmic reticulum-the microsomal ethanol-oxidising system; (3) in the endoplasmic reticulumthe NADH oxidase/catalase system. The cytosolic alcohol dehydrogenase reaction (fig 4) is the major ethanol-oxidising mechanism. Both this and the endoplasmic reticulum reactions result in acetaldehyde production. The acetaldehyde is further oxidised to acetate. These two reactions produce 2 
METABOLITES
The rise in blood lactate concentration was predicted from an increase in the rate of pyruvate reduction to lactate and a decrease in the rate of the reverse reaction, secondary to the redox changes. Though lactate concentration did not reach the values seen in diabetic lactic acidosis, the rate of rise was spectacular and showed no signs of decreasing at the end of the experiment. The use of ethanol in parenteral nutrition regimens, particularly in patients with impaired hepatic function, may predispose to significant lactic acidosis. In view of the high rate of lactate production, the low blood pyruvate concentrations were also expected. The small rise towards the end of the experiment may be explained by assuming a maximal rate of pyruvate reduction to lactate together with inhibition of oxidative phosphorylation and gluconeogenesis after the stage catalysed by lactate dehydrogenase, as suggested by Ylikahri." The striking increase in the lactate to pyruvate ratio reflects the accumulation of lactate. The lactate to pyruvate ratio gives an indication of the peripheral extramitochondrial NADH :NAD ratio. These results therefore illustrate the profound reduction of redox state that accompanies ethanol oxidation. The change of redox potential is also responsible for the increase of 3-hydroxybutyrate, the decrease of acetoacetate, and the resulting rise of the 3-hydroxybutyrate to acetoacetate ratio.
The rises in blood glycerol and free fatty acid concentrations suggest an increase in the rate of lipolysis. This may be caused by either (a) stimulation of catecholamine release from the adrenal medulla by ethanol (increasing tissue lipase activity) or (b) low plasma insulin concentration, or both. The overall rise and initial fall in blood free fatty acid concentration during ethanol infusion has also been observed by others. 14 These results differ from those of Abramson and Arky,6 who noted a decline in free fatty acid during ethanol infusion. This was due to a shorter (30-minute) infusion of ethanol. The rising free fatty acid and glycerol concentrations might also be accounted for by decreased utilisation. Lundquist et all' showed a decline in glycerol uptake in the splanchnic bed of man during ethanol administration, and a decrease in oxidation of free fatty acids could be secondary to the redox shift.
The observed fall in plasma growth hormone concentrations contrasted with the increase in response to fasting or insulininduced hypoglycaemia. Arky and Freinkel7 and Priem et al"6
published similar results. Evidence from Blackard et allshows that free fatty acids inhibit the release of growth hormone. The temporal correlation of a rise in free fatty acids and a fall in growth hormone in the present study supports this.
The overall response of cortisol was predictable, rising values being expected in response to progressive hypoglycaemia. Nevertheless, the plasma cortisol concentration rose significantly before an appreciable degree of hypoglycaemia had occurred. Other studies suggest that ethanol has a direct effect on the hypothalamus-pituitary-adrenal axis and that stimulation of adrenocorticotrophic hormone may be its basis. This may partly explain the pseudo-Cushing syndrome which occurs in chronic alcoholism. '8 There is widespread belief that potassium and glucose uptake by the tissues is linked. This hypothesis is inconsistent with the concomitant fall in plasma potassium concentration and Rd. In view of the decline in Ra, we suggest that hepatic potassium and glucose release is linked, as hypothesised by Zierler and Rabinowitz' 9 and by Brown et al. 20 Inhibition of gluconeogenesis in the fasted state may therefore cause hypokalaemia.
We conclude that ethanol induces hypoglycaemia in the fasted state by inhibiting gluconeogenesis. Accompanying this are widespread changes in intermediary carbohydrate and fat metabolism. These include raised lactate, 3-hydroxybutyrate, and free fatty acid concentrations. The observed reduction of redox state induced by ethanol oxidation probably explains these findings.
Ethanol-induced hypoglycaemia is accompanied by a reduction in growth hormone concentration, due possibly to inhibition of growth hormone release by free fatty acids. Plasma cortisol concentrations are raised during ethanol-induced hypoglycaemia, hypoglycaemia alone being an insufficient cause. A link between hepatic potassium and glucose release rather than peripheral potassium and glucose uptake is suggested.
Using ethanol as a source of energy in patients requiring parenteral nutrition may have serious consequences in hypoglycaemia, lactic acidosis, and hypokalaemia. Fifteen patients with hypertension due to phaeochromocytoma and 35 controls with essential hypertension were studied to assess the diagnostic value of urinary and plasma biochemical determinations in phaeochromocytoma.
In every case of phaeochromocytoma the urinary concentration of vanillylmandelate, metanephrines, or adrenaline plus noradrenaline was diagnostic of the disease irrespective of whether the patient was normotensive or hypertensive at the time. Plasma determinations of adrenaline and noradrenaline, however, gave falsely negative results on three occasions.
These findings suggest that urinary biochemical deter- 
